Dexmedetomidine Injectable Product

DRUG3 trials

Sponsors

Eye & ENT Hospital of Fudan University, Egyptian Biomedical Research Network, Hospital Clinic of Barcelona

Conditions

Acute Respiratory Distress SyndromeCesarean Section ComplicationsCytokine StormDelirium, EmergenceDexmedetomidineInflammationLaryngectomy; Status

Phase 3

Intravenous Dexmedetomidine in Cesarean Section Under Spinal Anesthesia

CompletedNCT04358367

Egyptian Biomedical Research NetworkCesarean Section Complications

Start: 2019-05-19End: 2019-11-19Updated: 2020-07-23

Unknown Phase

Effect of Dexmedetomidine in Preventing Cough and Postoperative Pain After Laryngeal Surgery for Cancer

Eye & ENT Hospital of Fudan UniversityLaryngectomy; Status

Start: 2019-05-01End: 2020-12-01Target: 120Updated: 2020-01-18

Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 Patients

Hospital Clinic of BarcelonaAcute Respiratory Distress Syndrome, Cytokine Storm, Delirium, Emergence +2

Start: 2020-04-15End: 2020-06-30Target: 80Updated: 2020-04-24

Related Papers

Dexmedetomidine versus midazolam on cough and recovery quality after partial and total laryngectomy – a randomized controlled trial

BMC Anesthesiology2020-09-288 citations